Rasha Aboelhassan/LinkedIn
Sep 27, 2024, 16:08
Rasha Aboelhassan has been accepted as a member of SPFG
Rasha Aboelhassan shared on LinkedIn:
“I’m proud to announce that I have been accepted as a member of staging and Prognostic Factors Group of lung cancer SPFG.
This group is a part of International Association for the Study of Lung Cancer.”
Source: Rasha Aboelhassan/LinkedIn
More posts featuring Rasha Aboelhassan oncodaily.com
Rasha Aboelhassan is a Senior Oncology Consultant at Nasser Institute Hospital. In addition to her clinical role, she volunteers as a reviewer for the World Journal of Surgical Oncology, contributing to advancements in the field and is in the Editorial Staff of Egyptian Journal of Human Genetics. Rasha has been accepted as a member of staging and Prognostic Factors Group of lung cancer SPFG.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 16, 2025, 22:31
Jan 16, 2025, 22:19
Jan 16, 2025, 22:17
Jan 16, 2025, 17:18
Jan 16, 2025, 16:45
Jan 16, 2025, 16:28
Jan 16, 2025, 16:10